These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 19893744

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.
    Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, Hackstadt T.
    Mol Microbiol; 2000 Aug; 37(4):913-25. PubMed ID: 10972811
    [Abstract] [Full Text] [Related]

  • 5. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
    Grieshaber S, Grieshaber N, Yang H, Baxter B, Hackstadt T, Omsland A.
    J Bacteriol; 2018 Jul 15; 200(14):. PubMed ID: 29735758
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.
    Slade JA, Brockett M, Singh R, Liechti GW, Maurelli AT.
    PLoS Pathog; 2019 Oct 15; 15(10):e1008078. PubMed ID: 31622442
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The chlamydial transcriptional regulator Euo is a key switch in cell form developmental progression but is not involved in the committed step to the formation of the infectious form.
    Appa CR, Grieshaber NA, Yang H, Omsland A, McCormick S, Chiarelli TJ, Grieshaber SS.
    mSphere; 2024 Sep 25; 9(9):e0043724. PubMed ID: 39140730
    [Abstract] [Full Text] [Related]

  • 12. The trans-Golgi SNARE syntaxin 10 is required for optimal development of Chlamydia trachomatis.
    Lucas AL, Ouellette SP, Kabeiseman EJ, Cichos KH, Rucks EA.
    Front Cell Infect Microbiol; 2015 Sep 25; 5():68. PubMed ID: 26442221
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tag-Dependent Substrate Selection of ClpX Underlies Secondary Differentiation of Chlamydia trachomatis.
    Wood NA, Swoboda AR, Blocker AM, Fisher DJ, Ouellette SP.
    mBio; 2022 Oct 26; 13(5):e0185822. PubMed ID: 36154190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis.
    Lee JK, Enciso GA, Boassa D, Chander CN, Lou TH, Pairawan SS, Guo MC, Wan FYM, Ellisman MH, Sütterlin C, Tan M.
    Nat Commun; 2018 Jan 03; 9(1):45. PubMed ID: 29298975
    [Abstract] [Full Text] [Related]

  • 19. The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence.
    Ong VA, Marsh JW, Lawrence A, Allan JA, Timms P, Huston WM.
    Front Cell Infect Microbiol; 2013 Jan 03; 3():100. PubMed ID: 24392355
    [Abstract] [Full Text] [Related]

  • 20. Chlamydia trachomatis persistence in vitro: an overview.
    Wyrick PB.
    J Infect Dis; 2010 Jun 15; 201 Suppl 2(Suppl 2):S88-95. PubMed ID: 20470046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.